To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Cannabis oralmucosal spray does not significantly improve neuropathic pain from multiple sclerosis

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2018

Cannabis oralmucosal spray does not significantly improve neuropathic pain from multiple sclerosis

Vol: 7| Issue: 10| Number:46| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

J Neurol. 2013 Apr;260(4):984-97. doi: 10.1007/s00415-012-6739-4

Contributing Authors:
S Ratcliffe W Notcutt RM Langford J Mares A Novotna M Vachova I Novakova

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

In a multicentre randomized trial, 339 patients with central neuropathic pain due to multiple sclerosis (MS) were randomized to receive either an oralmucosal spray containing THC and CBD (nabiximols) or placebo spray for 12 weeks, followed by an open-label and randomized-withdrawal phase for another 14 weeks. The primary outcome was at least 30% pain reduction, and secondary outcomes included time...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue